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ABSTRACT
Objectives: The aims of this study were to estimate house-
hold demand in the general population of Thailand for a
(hypothetical) preventive HIV vaccine; to determine whether
spouses in the same household would purchase the same
number of vaccines for household members and have the
same demand function; to determine whether spouses would
allocate vaccines to the same household members; and to
estimate household and per capita average willingness to pay
(WTP) for an HIV vaccine price.
Methods: The data come from a national contingent valua-
tion survey of 2524 residents (aged 18–20 years) of 1235
households in Thailand during the period 2000 to 2001. In a
subsample of 561 households, both head of household and
spouse completed independent (separate) interviews. Respon-
dents were asked whether they would purchase an HIV
vaccine for themselves and for other household members if
one were available at a speciﬁed price.
Results: For the full sample, average household WTP for the
vaccine was substantial (US$610 at 50% vaccine effective-
ness, US$671 at 95% effectiveness); the average per capita
WTP for household members was US$220 at 50% effective-
ness and US$242 at 95% effectiveness. Although spouses
reported that they would purchase the same total number of
vaccines, and had essentially the same demand functions, at
lower vaccine prices wives were signiﬁcantly more likely than
husbands to allocate vaccines to their daughters than to sons.
Conclusions: Because wives are more likely to allocate vac-
cines to daughters, vaccination programs aimed at women
and girls might have different outcomes than programs
directed at males or at all potential adults without regard
to sex.
Keywords: AIDS, contingent valuation method, HIV, intra-
household allocation, Thailand, vaccine demand, willingness
to pay.
Introduction
Studies conducted in Mexico [1], Kenya [2], Thailand
[3], and Uganda [4] to estimate private demand for a
(hypothetical) preventive HIV vaccine have all found
high willingness to pay (WTP) for self-protection.
These studies did not address whether an individual
might want to purchase HIV vaccines for other house-
hold members. Nor did they address whether spouses
in the same household have different preferences
regarding how many vaccines to purchase for house-
hold members and which household members should
receive them. The present study investigates these
questions.
We interviewed both head of household and spouse
separately to investigate the similarities and differences
in their preferences for a hypothetical preventive HIV
vaccine. Our results touch on crucial aspects of private
demand for an HIV vaccine. The sexual transmission
of HIV discourages open discussion in household con-
texts. Historically, the disease has afﬂicted sexes differ-
entially in various places and at various times; male
and female decision-makers may view the risks to
family members, the practicality of protection, and
prevention strategies differently.
There are at least two reasons why exploring house-
hold demand for a preventive HIV vaccine could be
valuable even before one is available. First, uncertainty
about the size of a future private market could discour-
age efforts to produce a vaccine. Estimates of aggregate
household private demand can help pharmaceutical
companies and public health planners to gauge the
potential market. This market could prove to be enor-
mous despite concerns that people with the highest risk
of infection live in developing countries, where ability
to pay for vaccines—either by governments or by
private purchasers—is low. For example, two recent
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policy papers from the International AIDS Vaccine
Initiative suggest that global demand for a preventive
HIV vaccine could reach several hundred million doses
in the early “catch-up” years, although logistical and
ﬁnancial constraints could reduce this by as much as
60% to 80% [5,6]. Because the costs of mass immu-
nization with such an expensive vaccine could over-
whelm available resources in many countries, even
with charitable aid, information is needed on private
demand, in both industrialized and developing coun-
tries, to assess whether planners can look to private
payments from individuals and families to cover at
least some of the vaccine’s cost.
Second, information on who buys vaccines, who
receives vaccines, and how preferences for vaccines
vary in a population, can enhance strategies for intro-
ducing and distributing the vaccine. For example, a
policy analysis of typhoid vaccination programs has
used information on private vaccine demand to show
how vaccine user charges can be set to maximize the
number of cases avoided subject to a constraint that no
new public health-care expenditures are needed; the
results show that adults should pay higher user charges
to cross-subsidize vaccines for children, the age group
with high incidence [7]. In the design of cholera vac-
cination programs, information on private vaccine
demand can be used to predict how many infants (who
are not eligible for the new generation cholera vac-
cines) might be protected via herd immunity by vacci-
nations among their household members [8,9].
This need for more nuanced information on vaccine
demand is particularly acute for HIV because men and
women face different risks from the disease and have
differential power with regard to decisions over sex
and money, and also because information available to
spouses about the sexual behavior of their partners
and other household members may not be the same
[10]. Biological factors play an important role, but
economic, social, and cultural factors also inﬂuence
how men and women experience the consequences of
the disease over time. Especially in parts of the world
where ﬁnancial dependence on men is necessary for
personal and family survival, women cannot always
control when, with whom, and in what circumstances
they have sex. In many countries women are not
expected to discuss sexuality, are not permitted to
insist on safe sex, and may risk sexual abuse if they do.
Women are thus more vulnerable to sexual exploita-
tion than men and more at risk of unprotected expo-
sure to HIV infection. Although both sexes are
susceptible to infection with the HIV virus, in some
parts of the world risk of infection among adolescent
girls is ﬁve to six times that faced by adolescent boys
[11]. Moreover, women also bear a disproportionate
burden of the social and economic costs of HIV [10].
In particular, women more frequently bear the psycho-
social and physical burden of AIDS care for self and
others [10]. As a consequence, UNAIDS, the United
Nations Population Fund, and the United Nations
Development Fund for Women have recommended
that HIV prevention programs be sex-based [11].
For these reasons, our research focused on investi-
gating differences between husbands’ and wives’
preferences for a preventive HIV vaccine for self-
protection and for other household members. Would
spouses differ in how many vaccines they would pur-
chase for the household? Would they allocate vaccines
to the same household members? Would their demand
functions (factors that inﬂuenced purchase decisions)
be similar?
It is usually assumed in microeconomic analyses
of household data, including data from contingent
valuation (CV) surveys, that either spouse can validly
represent the entire household regarding resource
allocation decisions. In this “common preferences”
model of household decision-making, spouses are
assumed to pursue the same objectives; from this
standpoint, it should not matter which spouse is
interviewed for a survey, as either would reply the
same. But numerous studies ﬁnd this model does not
characterize household decision-making for many
goods and services (see e.g., Lundberg et al. [12]).
Indeed, in 1996 Doss summarized the empiric tests of
the common preferences model available in the lit-
erature at that time and concluded that the predic-
tions from the common preferences model were
almost always rejected [13].
Research Design, Sample Characteristics, and
Survey Methods
Location and Sampling
Thailand was a natural choice for our study of spousal
preferences for a potential HIV vaccine, for several
reasons. The country presently experiences one of the
worst HIV epidemics in Asia. It also has been among
the most proactive in seeking solutions to HIV and
related problems. To date, Thailand has participated in
at least 10 HIV vaccine trials. The ﬁrst Phase III trial of
an HIV vaccine in a developing country was conducted
in Thailand. Partly as a result of these activities, the
public health community in Thailand has acquired
valuable experience regarding how an effective vaccine
might actually be used, and has already recognized the
potential value of reliable information on private
demand for an HIV vaccine as an aid to planning for
the introduction of such a vaccine when one becomes
available. The severity of the epidemic in Thailand
together with the widespread publicity surrounding
the recent Phase III vaccine trials suggested to us that
the Thai public in general would be better informed
about the concept of a preventive HIV vaccine than in
most other countries.
966 Whittington et al.
Our survey [3] was conducted between October
2000 and February 2001 in Bangkok and three prov-
inces preselected for various demographic attributes;
2524 adults were interviewed in 1235 households
(response rate 78%). After adjusting for various forms
of nonresponse and eliminating interview results in
which respondents proved unable to understand or
complete the survey, we achieved a ﬁnal full sample
totaling 1218 households. In a restricted sample of 561
of these households, both head of household and
spouse were interviewed separately.
The Survey Questionnaire
All participants in the survey received the same ques-
tionnaire [3], including spousal pairs in the subsample,
who were given the same questionnaire in their sepa-
rate interviews. The questionnaire gathered basic per-
sonal and attitudinal data, and then moved to a set of
questions designed to estimate the respondents’ WTP
for an HIV vaccine for self-protection and for other
household members. These questions about WTP for
vaccines and the associated information provided to
the respondent (together termed the “CV scenario”)
are the heart of a CV survey (see Mitchell and Carson
[14] and Bateman et al. [15] for thorough discussions
of the strengths and limitations of this survey method
for assigning monetary values to goods and services
not sold in markets).
The interviewer ﬁrst reminded the respondent that
HIV is a fatal disease, that it can be transmitted to
people in several ways (pictures of various transmis-
sion modes were shown), and that there were means
that an individual could use for self-protection against
infection. The interviewer then asked the respondent
to suppose that a (hypothetical) preventative vaccine
against HIV could be purchased. The interviewer
described the characteristics of the vaccine, emphasiz-
ing that: 1) the vaccine was 50% (or 95%) effective; 2)
it would last for 10 years; 3) it was completely safe; 4)
it would have no side effects; and 5) it was not curative
(i.e., it would not be effective for someone already
infected). Visual props were used to help the respon-
dent keep these characteristics of the hypothetical
vaccine clearly in mind throughout the presentation of
the CV scenario and valuation questions. The inter-
viewer also carefully explained what it means for a
vaccine to be 50% or 95% effective, using an illustra-
tive procedure developed speciﬁcally for the survey
(described in [3]).
The ensuing series of CV questions then inquired
whether the respondent would purchase the hypotheti-
cal vaccine for self-protection at a speciﬁed preas-
signed price. Subsequently, the interviewer asked
whether the respondent would purchase the vaccine
for other household members aged 10 years or older at
the same preassigned price, and, if so, for which house-
hold members the vaccine would be purchased.
(Within a given household, all adults interviewed
received questions with the same preassigned vaccine
efﬁcacy and price.)
The preassigned vaccine prices for the entire survey
ranged from 200 to 60,000 Baht, i.e., US$4.80 to
$1428.60 (US$1 = 42 Baht in 2000). These prices (bid
levels) were set to cover a wide range of income and
regional conditions in Thailand. We selected a low
price that 90% to 95% of respondents in the ﬁnal
sample would be likely to accept, and a high price
that only 5% to 10% of respondents would be likely
to accept, then distributed nine amounts between to
arrive at an array of 11 prices.
Modeling and Analyses
Following Cropper et al. [16], we used a count regres-
sion model to examine the factors associated with how
many HIV vaccines a respondent was willing to pur-
chase for household members. A count regression
model was chosen because it permits analysis of a
dependent variable (number of vaccines) that is neither
dichotomous (like a yes/no answer) nor continuous (it
did not permit fractions of vaccines). Even if spouses
would purchase the same number of vaccines for their
household, their decisions might be inﬂuenced by dif-
ferent factors. To test whether husbands and wives had
different demand functions, we estimated seemingly
unrelated negative binomial regression (SUR) models,
using the count of vaccines that husbands and wives
said they wanted to purchase as the dependent vari-
able. To test the estimated model coefﬁcients for wives
compared to those for husbands, we estimated demand
functions for husbands and wives independently, then
re-estimated them in an SUR framework.
To test whether husbands and wives would allocate
vaccines similarly among household members, we
estimated linear regression equations in which the
dependent variable was one of two ratios that we
constructed as indicators of intrahousehold vaccine
allocation. The ﬁrst, c:a, is the ratio of vaccines that
would be purchased for children to the vaccines that
would be purchased for adults. The second, f:m, is the
ratio of vaccines that would be purchased for females
to the vaccines that would be purchased for males.
The independent variables in these regressions were
average per capita income, average vaccine price,
average vaccine effectiveness, measures of average
household composition, and the interaction terms.
Rather than treating the ratios for each of the
respondents as the dependent variable, we followed
Lundberg et al. [12] and adopted a representative
household approach, classifying households into 396
different categories according to ﬁve variables: house-
hold size, income, vaccine price, vaccine effectiveness,
and respondent sex. We distinguished three categories
of per capita consumption and three categories of
household size—whether the household was in the top,
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middle, or bottom third of the sample distribution. We
kept the 11 preassigned vaccine prices and two levels
of vaccine effectiveness and added two categories for
respondent sex.
The averages of the two ratios were computed for
each household category as
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where h denotes the household category and Nh is the
total number of households in category h. Respec-
tively, c, a, f, and m measure one household in category
h’s stated demand for vaccines for children, adult,
female, and male household members.
The average ratios in Equation 1 were treated as
though they were the consumption patterns of repre-
sentative households in each category. Because this
approach averages over numerous households, we had
fewer undeﬁned ratios. To explore whether husbands’
and wives’ vaccine allocations were similar, we com-
pared the ratios reported by male respondents to the
ratios reported by female respondents. The ratios were
regressed on a set of independent variables that were
also category averages: average per capita consump-
tion, average household composition, and a set of
interaction terms that distinguished husbands’
responses from wives’. Household composition was
measured by the average number of adults, children,
females, males, female adults, female children, male
adults, and male children in each household category,
e.g., 1
1Nh n
N
h
h
=
∑ female children.
To construct a set of interaction terms that could
test for a difference in vaccine allocation between hus-
bands and wives, we deﬁned a variable D to be 0 when
the respondents in the category were husbands and 1
when the respondents were wives. We multiplied D by
average per capita consumption and by the variables
measuring average household size and composition
(number of adults, number of children, number of
female children, number of male children, number of
female adults, number of male adults). Signiﬁcant
results were interpreted as indicating that wives would
allocate vaccines differently than husbands. To our
knowledge, this exploratory modeling approach had
never previously been used to study households’
vaccine decisions.
Results of the Analysis
The Full Sample: Were Individuals Willing to
Purchase Vaccines for Other Household Members?
Table 1 offers a proﬁle of responses from the full sample
and the restricted sample. Estimates of household
demand from our full sample (answers from just one
adult respondent from each of the 1218 households)
can be viewed as results from a “common preferences”
model, in which either spouse may speak for both.
Table 2 shows that for the full sample, vaccine price had
a strong negative and statistically signiﬁcant effect on
the number of vaccines a respondent would be willing
to purchase for self-protection and for other household
members. The effects of both our income proxy (log of
per capita consumption) and household size (number of
people in the household aged 10 years or older) were
positive and signiﬁcant, indicating that people with
higher income and living in larger households would be
willing to buy more vaccines. Respondents who knew
someone infected with HIV would buy more vaccines,
as would respondents who lived in a rural area, or in the
northeast region of the country. Age had a negative
impact on demand for vaccines, but this effect was
statistically signiﬁcant only for the age group of 30 to
34 years. Surprisingly, respondents’ education, sex, or
marital status did not inﬂuence their household demand
for HIV vaccines, nor did vaccine effectiveness.
The Restricted Sample: Did Household Demand Vary
for Spouses in the Same Household?
Table 3 shows that for both husbands and wives the
mean number of vaccines the respondent said they
would purchase decreased as vaccine price rose. The
differences shown in mean demand are statistically
signiﬁcant in only eight of the 22 price/vaccine-efﬁcacy
combinations. In four of these, wives’ demand is
higher than husbands’; in the other four, husbands’
demand is higher than wives’.
These data do not provide strong evidence that
husbands and wives would purchase different numbers
of vaccines for household members. They do show that
husbands and wives were less likely to purchase the
same number of vaccines when vaccine prices were
low. At high prices, their decisions were more likely to
agree—but then, in the majority of cases, the decision
was to buy no vaccines at all.
The Restricted Sample: Do Spouses in the Same
Household Have Different Demand Functions
for HIV Vaccines?
The results of our SUR analyses are presented in
Table 2 (the variable deﬁnitions and their means and
standard deviations are reported in Table 1). The co-
efﬁcients for vaccine price are negative and highly
statistically signiﬁcant for both husbands and wives.
At a higher price, both spouses would purchase fewer
vaccines for the household. Wives who were offered
the 95% effective vaccine were willing to purchase
more vaccines than wives who were offered the 50%
effective vaccine; but this was not true for husbands.
Education had a positive and statistically signiﬁcant
effect on vaccine demand only for wives who had
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university or vocational education. Our income proxy
was positive for both husbands and wives in both SUR
model speciﬁcations, but it was statistically signiﬁcant
only for wives. Knowing someone with HIV was a
positive and statistically signiﬁcant determinant of
vaccine demand for husbands, but not for wives. The
number of people in a household who were 10 years of
age or older (and thus potentially eligible to receive a
vaccine as speciﬁed in the CV scenario) had a positive
effect on both husbands’ and wives’ demand for
vaccines.
These multivariate results suggest that the vaccine
demand functions for husbands and wives are not
statistically different from each other. To verify this, we
conducted separate and joint tests of hypotheses in
which we compared all the coefﬁcients for husbands’
demand to the corresponding coefﬁcients for wives’
demand. The results for the separate tests (presented in
the last column of Table 2) indicate that husbands’
household demand differed signiﬁcantly from wives’
only if the household: 1) was from northern, rural
Thailand; 2) had vocational education; or 3) knew a
person with HIV. For all other variables, the coefﬁcient
for husbands’ demand was not signiﬁcantly different
from that for wives’ demand. We then compared all the
coefﬁcients for husbands’ demand to the correspond-
ing coefﬁcients for wives’ demand jointly. We were
unable to reject the joint hypothesis that both hus-
bands and wives have the same demand functions
(c2 = 0.54).
Did Spouses Demand Vaccines for the Same
Household Members?
To examine whether husbands and wives would allo-
cate HIV vaccines to the same household members, we
used the multivariate approach described in Equa-
tion 1. The third, fourth, and ﬁfth columns in Table 4
show the results of the regressions when the dependent
variable is the ratio of average stated demand for vac-
cines for children to the average stated demand for
vaccines for adults (c:a). The parameter estimates can
be interpreted as the relative increase in number of
vaccines purchased for children when the correspond-
ing independent variable increases by one unit. A
Table 1 Characteristics of respondents: full and restricted samples
Variable name Description
Full sample
(n = 1218
households)*
Restricted sample
(n = 561 households)
Wives (n = 561)
Husbands
(n = 561)
Mean SD Mean SD Mean SD
Respondent’s demographic characteristics
Sex 1 = if male 0.59 0.49 0 0 1 0
Married 1 = if married 0.72 0.44 1 0 1 0
Age (year) 42.11 10.30 39.94 8.80 43.18 9.17
25–29 1 = this age, 0 otherwise 0.07 0.25 0.10 0.30 0.06 0.24
30–34 1 = this age, 0 otherwise 0.12 0.33 0.13 0.34 0.12 0.33
35–39 1 = this age, 0 otherwise 0.15 0.35 0.21 0.41 0.15 0.36
40–44 1 = this age, 0 otherwise 0.18 0.38 0.22 0.41 0.20 0.40
45–49 1 = this age, 0 otherwise 0.16 0.37 0.14 0.35 0.17 0.38
50 1 = this age, 0 otherwise 0.27 0.44 0.16 0.37 0.28 0.45
Household size Number in household aged 10 or older 3.14 1.42 3.83 1.39 3.83 1.39
Respondent’s education (base: no education)
Elementary 1 = completed no more than elementary school
but had some schooling, 0 otherwise
0.59 0.49 0.69 0.46 0.64 0.48
Secondary 1 = completed secondary school, 0 otherwise 0.16 0.36 0.13 0.33 0.17 0.38
University 1 = completed university, 0 otherwise 0.15 0.35 0.08 0.27 0.11 0.31
Vocational 1 = completed vocational training, 0 otherwise 0.09 0.28 0.06 0.25 0.07 0.26
Vaccine characteristics
Price offered Price offered to respondent (US$1000) 0.36 0.45 0.36 0.45 0.36 0.45
Effectiveness 1 = 95%, 50% otherwise 0.50 0.50 0.50 0.50 0.50 0.50
Respondent’s economic characteristics
Log of per capita monthly consumption Per capita monthly consumption 7.92 0.74 7.74 0.67 7.74 0.67
Respondent risk
Perception of lifetime risk of getting AIDS 1 = if some or large lifetime risk, 0 otherwise 0.42 0.49 0.42 0.49 0.43 0.50
Does not know lifetime risk of getting AIDS 1 = don’t know, 0 otherwise 0.06 0.24 0.07 0.25 0.05 0.23
Respondent’s geographic characteristics
(area of residence in Thailand)
Urban area, central region 1 = central urban, 0 otherwise 0.06 0.23 0.05 0.21 0.05 0.21
Urban area, north region 1 = north urban, 0 otherwise 0.05 0.22 0.03 0.18 0.03 0.18
Bangkok 1 = Bangkok, 0 otherwise 0.33 0.47 0.25 0.43 0.25 0.43
Urban area, northeast region 1 = northeast urban, 0 otherwise 0.08 0.27 0.09 0.28 0.09 0.28
Urban area, south region 1 = south urban, 0 otherwise 0.04 0.21 0.05 0.21 0.05 0.21
Rural area, south region 1 = south rural, 0 otherwise 0.12 0.32 0.17 0.37 0.17 0.37
Rural area, north region 1 = north rural, 0 otherwise 0.14 0.34 0.14 0.35 0.14 0.35
Rural area, northeast region 1 = northeast rural, 0 otherwise 0.12 0.32 0.14 0.35 0.14 0.35
*Respondent is either head of household, the spouse of the head of household, or the oldest household member interviewed.
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Table 2 Vaccine demand functions: full sample and seemingly unrelated regression on restricted sample of spouses (dependent
variable = count of number of vaccines respondent would purchase)
Full sample
(1218 households)
Restricted sample (561 households)
Results for wife Results for husband Test of Ho : bw = bh
Vaccine price -1.79
(-11.05)***
-1.74
(-5.71)***
-1.92
(-6.06)***
NR
Vaccine effectiveness 0.09
(1.03)
0.24
(2.1)**
0.01
(0.04)
NR
Log of per capita monthly consumption 0.19
(2.00)**
0.24
(2.04)**
0.14
(1.07)
NR
Education
Elementary 0.11
(0.29)
0.63
(1.31)
-0.31
(-0.62)
NR
Secondary 0.15
(0.38)
0.80
(1.56)
-0.28
(-0.53)
NR
University 0.39
(0.95)
0.97
(1.9)*
-0.04
(-0.08)
R*
Vocational 0.05
(0.13)
1.08
(1.98)**
-0.38
(-0.66)
NR
Age (year)
25–29 -0.19
(-0.74)
0.10
(0.32)
-0.24
(-0.6)
NR
30–34 -0.40
(-1.69)*
0.15
(0.47)
-0.44
(-1.1)
NR
35–39 -0.12
(-0.52)
0.12
(0.37)
-0.35
(-0.9)
NR
40–44 -0.10
(-0.47)
0.16
(0.49)
-0.32
(-0.83)
NR
45–49 -0.12
(-0.52)
0.24
(0.73)
-0.45
(-1.09)
NR
50 -0.36
(-1.6)
0.10
(0.29)
-0.51
(-1.27)
NR
Household size 0.16
(4.51)***
0.20
(3.31)***
0.20
(3.26)***
NR
Perception of lifetime risk of getting AIDS 0.15
(1.6)
0.17
(1.3)
0.14
(1.12)
NR
Does not know lifetime risk of getting AIDS 0.21
(1.05)
0.10
(0.43)
-0.01
(-0.04)
NR
Rate of time preference -0.02
(-3.28)***
-0.02
(-1.77)*
-0.01
(-1.09)
R*
Respondent knows person with AIDS 0.32
(3.12)***
0.16
(1.2)
0.48
(3.31)***
NR
Geographic characteristics
Urban area, central region -0.06
(-0.21)
-0.18
(-0.45)
-0.20
(-0.48)
NR
Urban area, north region 0.09
(0.33)
0.58
(1.64)*
0.48
(1.16)
NR
Bangkok 0.15
(0.71)
0.23
(0.81)
0.30
(0.97)
NR
Urban area, northeast region 0.08
(0.32)
0.60
(1.78)*
0.46
(1.4)
NR
Urban area, south region -0.07
(-0.25)
-0.08
(-0.25)
0.28
(0.76)
NR
Rural area, south region -0.10
(-0.4)
0.36
(1.27)
0.09
(0.27)
R*
Rural area, north region 0.01
(0.03)
0.57
(1.99)**
0.06
(0.2)
NR
Rural area, northeast region 0.53
(2.41)†
0.82
(2.97)***
0.83
(2.60)***
NR
Sex 0.14
(1.39)
Respondent is married 0.16
(1.29)
Constant -2.27
(-2.66)***
-3.76
(-3.39)***
-1.33
(-1.2)
Log (alpha) -0.16 -0.33 -0.28
*Statistically signiﬁcant at the 10% level.
**Statistically signiﬁcant at the 5% level.
***Statistically signiﬁcant at the 1% level.
NR, not able to reject the null hypothesis Ho : bw = bh; R, null hypothesis Ho : bw = bh is rejected.
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positive estimate implies that an increase in the inde-
pendent variable corresponds to an increase in the
number of vaccines purchased for children (10–
18 years old) that is greater than the increase in
vaccines purchased for adults.
All else equal, results in Table 4 indicate that both
husbands and wives would purchase more vaccines for
children when there were more children in the house-
hold, whether boys or girls. In Model 1, where the
parameters relating to average numbers for boys and
girls are positive and statistically signiﬁcant, for each
additional boy or girl in the household, the respondent
would purchase about 0.3 more vaccines for children
than for adults. In Model 2, where the parameter on
average number of children in the household category,
nchild, is statistically signiﬁcant, for each additional
child in the household the respondent would purchase
0.29 more vaccines for children than for adults. The
impact of the number of household adults on vaccine
allocation is not statistically signiﬁcant in any of these
cases.
This positive impact of number of eligible children
on stated demand for vaccines for children disappears
when the respondent is female and the number of boys
in the household increases. In Model 1, the statistically
signiﬁcant negative result on the interaction between
average number of boys and respondent sex (fboys)
indicates that as the number of boys in the household
increases, wives would buy fewer vaccines for children
than for adults. The parameters here and for average
number of boys (boys) are nearly the same in magni-
tude but have opposite signs, suggesting that wives
would not purchase more vaccines for children when
the number of boys increases. In fact, the sum of the
two estimates indicates that when there are more boys
in the household, women would buy slightly fewer
vaccines for children than for adults. Comparable
results for girls and sex of the respondent (girls, fgirls)
are not signiﬁcant.
Results for Models 3 and 4 in Table 4 compare
average stated demand for vaccines for females to
average stated vaccine demand for males. These results
indicate that husbands and wives purchase more
vaccines for females whenever there are more
females—girls or women—in the household: results at
f in Model 3 and girls and lady in Model 4 are positive
and signiﬁcant. As the number of males increases,
respondents purchase relatively fewer vaccines for
females: results at m in Model 3 and boys in Model 4
are negative and signiﬁcant.
The models in Table 4 offer little evidence that
spouses would purchase more vaccines for female
adults than for male adults. The parameter ﬁnc is not
signiﬁcant in any of the models, an indication that the
effect of income is the same for husbands and wives in
regard to allocation of vaccines between children and
adults, or between females and males.
Household WTP for HIV Vaccines
Following Cropper et al. [16], the parameter estimates
from the demand function for both husbands and
wives (Table 2) were used to estimate average house-
hold WTP, as shown in Table 5. Average per capita
WTP was calculated by dividing household WTP by
the number of household members aged 10 years or
Table 3 Mean number of vaccines “purchased,” by price and efﬁcacy; and t-tests of mean equivalence across subsamples
Vaccine
price (US$)
50% effective vaccine 95% effective vaccine
Husband
meanH
Wife
meanW
Test of
H0 : meanH =meanW
Husband
meanH
Wife
meanW
Test of
H0 : meanH =meanW
5 1.73
(1.64)
2.27
(1.31)
R 2.00
(1.62)
1.42
(1.25)
R
12 1.89
(1.57)
1.11
(1.23)
R 1.29
(1.30)
1.86
(1.53)
R
24 1.04
(1.22)
0.78
(0.90)
1.39
(1.45)
1.26
(1.29)
71 0.91
(1.16)
0.65
(1.03)
1.04
(1.51)
1.04
(1.43)
119 0.59
(1.05)
0.59
(1.15)
0.46
(1.00)
1.07
(1.41)
R
179 0.76
(1.13)
0.12
(0.44)
R 0.26
(1.29)
0.82
(1.14)
238 0.74
(0.99)
1.00
(1.56)
0.33
(0.70)
1.04
(1.20)
R
357 0.75
(1.19)
0.63
(1.01)
0.57
(1.04)
0.13
(0.34)
R
476 0.65
(1.39)
0.54
(0.90)
0.38
(0.67)
0.62
(1.16)
952 0.10
(0.31)
0.03
(0.19)
0.29
(0.75)
0.29
(1.08)
1429 0.04
(0.20)
0.08
(0.27)
0.28
(0.84)
0.38
(0.98)
R, null hypothesis Ho; meanH, meanW is rejected at the 10% level.
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older. For the full sample, average household WTP for
the vaccine was US$610 at 50% vaccine effectiveness
and US$671 at 95% effectiveness; the average per
capita WTP for household members was US$220 at
50% effectiveness and US$242 at 95% effectiveness.
These household WTP estimates can be interpreted as
measures of the private economic beneﬁts an average
household would receive if all of its members aged
10 years or older received an HIV vaccine free of
charge.
Table 4 Multivariate analysis of husbands’ and wives’ allocations of vaccines among household members (t-statistics in parentheses)
Variable
name
Variable deﬁnitions for models of intrahousehold
vaccine demand
Model 1 (181)
child : adult
Model 2 (181)
child : adult
Model 3 (192)
female : male
Model 4 (192)
female : male
cons Constant 0.50**
(2.13)
0.52**
(2.33)
0.69**
(3.33)
0.59**
(2.49)
conspc Per capita consumption (Baht) 0.00
(0.51)
0.00
(0.39)
0.00
(-0.39)
0.00
(-0.22)
ﬁnc Interaction between respondent sex and per capita consumption
(sex* onspc)
0.00
(-0.09)
0.00
(-0.25)
0.00
(0.02)
0.00
(0.02)
boys Number of male household members 10–18 years of age 0.31**
(2.39)
-0.26†
(-2.05)
girls Number of female household members 10–18 years of age 0.28**
(2.04)
0.45***
(3.21)
fboys Interaction between respondent sex and boys (sex* boys) -0.33*
(-1.89)
-0.11
(-0.63)
fgirls Interaction between respondent sex and girls (sex* girls) 0.12
(0.64)
-0.06
(-0.32)
gent Number of male household members more than 18 years of age -0.15
(-0.90)
-0.28
(-1.17)
lady Number of female household members more than 18 years of
age
-0.13
(-0.86)
0.53*
(2.58)
fffad Interaction term between respondent sex and lady (sex* lady) 0.12
(0.68)
-0.42*
(-1.64)
fmad Interaction term between respondent sex and gent (sex* gent) 0.30
(1.12)
price1 Offered price of vaccine 0.00
(0.63)
0.00
(0.94)
0.00
(-0.65)
0.00
(-0.92)
eff Effectiveness of vaccine -0.26***
(-2.55)
-0.26***
(-2.51)
-0.10
(-0.95)
-0.10
(-1.00)
nchild Number of household members 10–18 years of age 0.29*
(2.94)
fkids Interaction term between respondent sex and nchild (sex* nchild) -0.10
(-0.75)
nadult Number of household members more than 18 years of age -0.14
(-1.60)
fad Interaction term between respondent sex and nadult (sex* nadult) 0.06
(0.61)
m Number of male household members -0.27***
(-2.90)
f Number of female household members 0.46***
(5.13)
fmale Interaction term between respondent sex and number of males
(sex* m)
-0.03
(-0.21)
ffem Interaction term between respondent sex and number of females
(sex* f )
-0.14
(-1.19)
R2 0.14 0.11 0.22 0.24
*Statistically signiﬁcant at the 10% level.
**Statistically signiﬁcant at the 5% level.
***Statistically signiﬁcant at the 1% level.
Table 5 Average household and per capita WTP for a (hypothetical) HIV vaccine, by vaccine effectiveness and subsample (US$)
Vaccine
effectiveness
Restricted sample (n = 561 households) Full sample*
(n = 1218 households)Husband Wife Simulation*
Household
WTP
Per capita
WTP
Household
WTP
Per capita
WTP
Household
WTP
Per capita
WTP
Household
WTP
Per capita
WTP
50% 684 226 636 212 666 221 610 220
95% 687 227 809 269 751 249 671 242
*Mean WTP from 100 repetitions of a random draw of one respondent per household.
WTP, willingness to pay.
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Discussion and Conclusion
Our ﬁndings reported here from ﬁeld research in Thai-
land add to the growing literature on private demand
for HIV vaccines in several ways. Substantial average
WTP estimates from households where both spouses
were interviewed separately show that husbands and
wives alike expressed great interest in a (hypothetical)
HIV vaccine, not only for self-protection but also for
other household members aged 10 years or older.
Average household WTP from our survey ranged from
$610 to $809 depending on who in the household was
asked and the effectiveness of the vaccine, providing
strong evidence that the perceived private beneﬁts of
making an HIV vaccine available to households in
Thailand could be much larger than the economic
beneﬁts of currently available vaccines for other
diseases.
In our survey, husbands and wives did not differ
signiﬁcantly in the total number of vaccines they
would purchase for other household members, or in
determinants of demand. At the highest prices offered
in our CV scenario, there was little room for difference
between spouses as to who within the household
would receive HIV vaccines, because most households
would not have purchased any vaccines at all. At lower
prices, however, in numerous households husbands
and wives did differ in how they would have allocated
vaccines among household members: speciﬁcally,
wives were less inclined to purchase vaccines for male
household members, especially for male children and
teenagers. This may reﬂect a belief, supported by con-
siderable evidence [10,11], that the risks of incurring
HIV are higher for females than for males. This ﬁnding
that spouses may differ in allocating vaccines pur-
chased for household members suggests that vaccina-
tion programs aimed at females, as proposed by some
international agencies active in HIV planning and
research, could have different health outcomes than
programs directed at males or at all potential purchas-
ers without regard to sex.
More generally, the stated preference (CV) data
from our survey capture important information about
husbands’ and wives’ preferences for HIV vaccines,
recorded in separate, individual interviews without the
opportunity to consult with each other to present a
consensus on what their household would actually do.
In some households, husbands and wives appear to
have been of like mind. In other households, spouses’
preferences seem to have been far apart. The ﬁnal
market demand for HIV vaccines will depend greatly
on how such intrahousehold allocation decisions are
worked out. Our evidence does not extend that far, but
it does conﬁrm that reliance merely on the individual
respondent’s stated demand for such a vaccine for
self-protection could signiﬁcantly underestimate
market demand.
This study was subject to some limitations. CV
questions of the kind used here sometimes suffer from
“yea saying”: respondents may say “yes” to a valua-
tion question simply with the aim of pleasing the inter-
viewer or for other reasons [17–19]. Various survey
protocols have been suggested to avoid this and other
types of hypothetical bias, including cheap talk scripts
in the questionnaire [19], using drop-off surveys
instead of in-person interviews [20,21], and giving
respondents more time to think (e.g., overnight) about
their answers to valuation questions [22]. The study
presented here did not employ such protocols, which
remain untested in research on household demand for
HIV vaccines.
Results from CV surveys also suffer from low sta-
tistical efﬁciency [23]. An alternative prospect for
future research is the application of “choice model”
techniques to study intrahousehold vaccine demand
issues. Choice modeling experiments collect much
more valuation data from each respondent in a
survey than are commonly gathered for CV studies,
and in this sense are more efﬁcient. Choice models
have been used to estimate respondent demand for
typhoid and cholera vaccines [24,25] but have not
yet been used to study demand for HIV vaccines or
demand by husbands and wives in the same house-
hold for any vaccine.
A fruitful area for future research would be to test-
market new generation vaccines that do exist (e.g., for
cholera, typhoid) to see how answers to hypothetical
questions about vaccine demand differ from actual
purchase decisions. Experimental evidence from actual
test markets of vaccine sales could also be used to
explore intrahousehold vaccine demand.
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